Follows initiation of Phase 1a/1b study in the U.S. Company plans to include clinical centers in China to broaden geographic representation and accelerate patient enrollment into the Phase 1a/1b study SAN DIEGO and SHANGHAI, May 6, 2024 /PRNewswire/ — Adcentrx Therapeutics (“Adcentrx”),…
Month: May 2024
HONG KONG, May 6, 2024 /PRNewswire/ — CNOOC Limited (the “Company”, SEHK: 00883 (HKD Counter) and 80883 (RMB Counter), SSE: 600938) announces today that Bozhong 19-6 Gas Field 13-2 Block 5 Well Site Development Project has commenced production. The project is located in central Bohai…
NEW YORK, May 6, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Rayonier Advanced Materials Inc. (“Rayonier” or the “Company”) (NYSE: RYAM). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The…
NEW YORK, May 6, 2024 /PRNewswire/ — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of AST SpaceMobile, Inc. (NASDAQ: ASTS) between November 14, 2023 and April 1, 2024, both dates inclusive (the “Class Period”), of the important June 17, 2024…
NEW YORK, May 6, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Zevra Therapeutics, Inc. (“Zevra” or the “Company”) (NASDAQ: ZVRA). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The…